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It’s now cheaper to print color figures in KI
Have you been concerned in the past about the cost of print-
ing color figures in Kidney International (KI)? KI has listened 
to your concerns and is now offering permanently reduced 
pricing for color figures—a flat fee of $500 per printed page, 
no matter how many color figures are on a page. This pricing 
is more affordable for authors and competitive with other top 
scientific journals. We want to make it easier for authors to 
publish the color figures that demonstrate important scien-
tific findings, and our new pricing reflects our commitment to 
achieving this goal.
Fibrinogen causes 
proliferation of 
interstitial cells 
during induction of 
renal fibrosis
Fibrinogen, the classic protein of coag-
ulation, has been implicated in other 
functions, especially in inflammation 
and fibrosis. As they report in this issue, 
Sörensen et al. used a model of renal 
fibrosis (unilateral ureteric obstruction, 
where fibrinogen gets deposited in the 
interstitium) to study fibrinogen’s role in 
renal fibrosis. They induced this model 
in wild-type mice and compared them 
with those whose fibrinogen gene was 
deleted. The mutant mice had much less 
fibrosis, though not because of reduced 
infiltration by inflammatory cells, but 
rather because of reduced proliferation 
of interstitial cells. See page 1035.
No benefit from 
frequent nocturnal 
hemodialysis
Nocturnal hemodialysis can be per-
formed daily, and small studies have 
suggested that the increase in dialysis 
time would improve the outcome of 
patients with end-stage renal disease. 
However, Rocco et al. conducted a 
much larger randomized trial compar-
ing frequent nocturnal hemodialysis 
with conventional hemodialysis. The 
patients receiving nocturnal hemodial-
ysis had almost twice the dialysis time. 
Other than better control of hyperphos-
phatemia and blood pressure, there was 
no benefit in primary or secondary out-
comes. The authors found no effect on 
death or left ventricular mass, nor did 
they find a significant benefit in second-
ary outcomes such as cognitive perfor-
mance, depression, laboratory markers 
of nutrition, mineral metabolism, or 
anemia. See page 1080.
Vitamin D  
increases serum 
creatinine without 
changing glomerular 
filtration rate
When patients receive vitamin D, 
their serum creatinine often increases. 
Although the obvious mechanism 
would be a worrisome reduction in 
glomerular filtration rate (GFR), Agar-
wal and colleagues performed continu-
ous creatinine clearance measurements 
before, during, and after administra-
tion of paricalcitol, a vitamin D recep-
tor activator. As expected, parathyroid 
hormone levels decreased, and then 
rebounded after cessation of therapy. 
Serum creatinine increased by 0.01 
mg/dl every day, but the urine creati-
nine increased as well by about 18 mg 
per day. Iothalamate clearances did not 
increase. Hence, vitamin D analogs 
increase creatinine production without 
changing GFR. How they can increase 
the non-enzymatic hydrolysis of creati-
nine is the new mystery. See page 1073.
